Life
Automation of Screening Studies for Compounds that Slow Aging is Becoming More Ambitious
Screening compound libraries for effects on aging in short-lived species has grown to become a significant area of inter…
Life
1157 articles
Life
Opinion: Autonomous AI will beat AI-assisted physicians at some medical tasks by 2030
“Autonomous AI will likely soon exceed both unaided physicians and physicians aided by AI at five core cognitive medical…
Life
Opinion: AMA CEO: AI won’t replace doctors — it will work alongside them
“The goal should not be to reproduce today’s health care system with fewer humans,” writes American Medical Association …
Life
3D Culture Reverses Limbal Niche Cell Replicative Aging via FOSL1 Upregulation
Aging Cell, Volume 25, Issue 9, September 2026.…
Life
Why GLP-1s Could Be an Anti-Aging Breakthrough - National Geographic
Why GLP-1s Could Be an Anti-Aging Breakthrough National Geographic…
Life
STAT+: FDA names acting heads of drug and vaccine centers to permanent roles
The moves bring stability to an agency that's been rocked by the exits of top leadership.…
Life
The Adaptive Cost Hypothesis of Aging, a Viewpoint on Antagonist Pleiotropy
At the high level, without delving into specific mechanisms, the consensus view on aging is that it exists in the shadow…
Life
Heritability of intrinsic human life span is about 50% when confounding factors are addressed - Science | AAAS
Heritability of intrinsic human life span is about 50% when confounding factors are addressed Science | AAAS…
Life
STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals
The FDA warned a supplier of active pharma ingredients about residue on walls, a corroded product line, and open-toed sa…
Life
Late-Life GLP-1 Treatment Increases Lifespan in Female Mice
In a new study, semaglutide given late in life increased median lifespan in female mice by more than 12% and […]…
Life
STAT+: UnitedHealth’s Democrat investment, and surprise billing bloat debate
UnitedHealth execs shower a top Democrats with cash, and the No Surprises Act debate heats up.…
Life
STAT+: Health care features prominently in Democrats’ agenda
Democrats are sharpening their health care plans as the midterm elections near.…
Life
STAT+: Oura goes public, reported $1.2B earnings in its last fiscal year
In health tech news today, Oura reports a profit, the FDA loses another key digital health leader, and more…
Life
Insilico AI candidate rentosertib reverses proteomic aging clocks
Insilico Medicine published a study in Nature Biotechnology reporting that its AI-designed idiopathic pulmonary fibrosis…
Life
STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more
An experimental Novartis drug for a rare neuromuscular condition failed to improve muscle function in a pivotal study…
Life
STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the mar…
Life
An administrative gap delays access to new pancreatic cancer treatment
A new wave of illegal fruity vapes, more and more kids on GLP-1s, and other health news from Morning Rounds…
Life
STAT+: Inhibrx claims first win for long-sought immunotherapy target
“Pushing this is like a rock up a hill, because there’s been so much failure in the space,” said Inhibrx CEO Mark Lappe.…
Life
Dogs Exhibit Comorbidity and Mortality Risk in Much the Same Way as Humans
One of the goals of the Dog Aging Project is to better establish that the characteristics of aging in dogs are close eno…
Life
Age Acceleration in Various Proteomic Clocks Correlates with Risk of Mortality and Age-Related Disease
In recent years, researchers have been gathering as much data as possible on the behavior of aging clocks of various sor…
Life
STAT+: Roivant lung disease drug hits mid-stage study goals
These positive results could open up a new way to treat serious lung disease.…
Life
Reynolds is selling fruity new vapes unauthorized by FDA
The decision to move ahead with new products in the absence of FDA authorization could spur other big manufacturers to d…
Life
A breakthrough pancreatic cancer drug won approval. They still struggle to access it
When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for…
Life
STAT+: Neuromuscular drug from Novartis fails in key study, adding to pressure on company
A Novartis drug for a rare neuromuscular condition failed in a key study, the company's second major trial collapse in a…